Cargando…
Myxedema Coma: Improving Outcomes With Prompt Recognition and Therapy
Background: Myxedema coma, a misnomer for severe hypothyroidism, is a rare endocrine emergency with an incidence of 1.08 cases per million people per year and a high mortality rate ranging from 30-50%. A delay in diagnosis and treatment worsens the prognosis and increases morbidity and mortality. De...
Autor principal: | Parihar, Aisha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089968/ http://dx.doi.org/10.1210/jendso/bvab048.1927 |
Ejemplares similares
-
Myxedema Coma Disguised as Alcohol Withdrawal
por: Pahwa, Dhivya, et al.
Publicado: (2021) -
SUN-584 Unusual Presentation Of Myxedema Coma
por: Murati, Jonila, et al.
Publicado: (2019) -
SAT-624 Amiodarone-Induced Myxedema Coma
por: Rana, Sanah, et al.
Publicado: (2019) -
SUN-550 Pressor Refractory, Liothyronine Responsive Myxedema Cardiogenic Shock without Myxedema Coma
por: Willis, Cornelia, et al.
Publicado: (2019) -
SAT-LB83 Amiodarone Induced Myxedema Coma
por: Kim, Keun Young, et al.
Publicado: (2020)